CD8A and nephrolithiasis: Based on our findings and what has been discussed above, we propose the following hypothesis for the application of immunotherapy against KSD: firstly, we can design a multiple-epitope peptide vaccine that induces a CD8 + T-cell immune response to directly kill bacteria in infected kidney stones.